Zhengye Biotechnology Holding (ZYBT) Debt to Equity (2023 - 2025)
Historic Debt to Equity for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $0.01.
- Zhengye Biotechnology Holding's Debt to Equity changed N/A to $0.01 in Q2 2025 from the same period last year, while for Jun 2025 it was $0.01, marking a year-over-year change of. This contributed to the annual value of $0.03 for FY2024, which is 8715.78% down from last year.
- Per Zhengye Biotechnology Holding's latest filing, its Debt to Equity stood at $0.01 for Q2 2025.
- In the past 5 years, Zhengye Biotechnology Holding's Debt to Equity ranged from a high of $0.26 in Q4 2023 and a low of $0.01 during Q2 2025
- Moreover, its 3-year median value for Debt to Equity was $0.03 (2024), whereas its average is $0.1.
- The largest annual percentage gain for Zhengye Biotechnology Holding's Debt to Equity in the last 5 years was 8715.78% (2024), contrasted with its biggest fall of 8715.78% (2024).
- Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Debt to Equity stood at $0.26 in 2023, then crashed by 87.16% to $0.03 in 2024, then plummeted by 60.54% to $0.01 in 2025.
- Its Debt to Equity was $0.01 in Q2 2025, compared to $0.03 in Q4 2024 and $0.26 in Q4 2023.